Kozo Yoshimori

11.9k citations
65 papers · 1.6k indexed · 1 hit paper · h-index 14
Topics
Mycobacterium research and diagnosis (16 papers)Tuberculosis Research and Epidemiology (14 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers)
Partner nations
JapanUnited StatesIsrael

In The Last Decade

Kozo Yoshimori

54 papers receiving 1.6k citations

Hit Papers

Updated overall survival results from a randomized phase ...20122026201620212012100200300400

Peers

Kozo Yoshimori
Comparison fields: 5 of 91
  • Pulmonary and Respiratory Medicine 824
  • Oncology 706
  • Physiology 336
  • Epidemiology 321
  • Molecular Biology 288
Replace Giovanni Vicidomini with:
Giovanni Vicidomini Italy
Kojiro Otsuka Japan
Shin Akagawa Japan
Sumin Shin South Korea
Takuma Yokoyama Japan
J. Enrique Domínguez‐Muñoz Spain
Michael Gibbons United Kingdom
Sung Eun Kim South Korea
Yuki Yoshimatsu Japan
Satoshi Marumo Japan
Kozo Yoshimori relative to Giovanni Vicidomini Italy Giovanni Vicidomini's profile →
Citations per field
00.5×4.6×
Giovanni Vicidomini · 1×
Citations per year

Countries citing papers authored by Kozo Yoshimori

Since Specialization
Citations

This map shows the geographic impact of Kozo Yoshimori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kozo Yoshimori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kozo Yoshimori more than expected).

Fields of papers citing papers by Kozo Yoshimori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kozo Yoshimori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kozo Yoshimori. The network helps show where Kozo Yoshimori may publish in the future.

Co-authorship network of co-authors of Kozo Yoshimori

This figure shows the co-authorship network connecting the top 25 collaborators of Kozo Yoshimori. A scholar is included among the top collaborators of Kozo Yoshimori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kozo Yoshimori. Kozo Yoshimori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 0
4 2
5 3
6 0
7 2
8 10
9 2
10 2
11 8
12 11
13 0
14 57
15 1
16 74
17 141
18 2
19
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)breakdown →
427
20 17

About Kozo Yoshimori

Kozo Yoshimori is a scholar working on Microbiology, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 65 papers that have together received 1.6k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (16 papers), Tuberculosis Research and Epidemiology (14 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers). The work is most often cited by research in Oncology (706 citations), Pulmonary and Respiratory Medicine (824 citations) and Microbiology (14 citations). Kozo Yoshimori has collaborated with scholars based in Japan, United States and Israel. Frequent co-authors include Nobuyuki Katakami, Akihiko Gemma, Hirohisa Yoshizawa, Minoru Kawahara, Kozo Morimoto, Yuichi Takiguchi, Hiroshi Isobe, Takashi Yoshiyama, Toshiyuki Harada and H Niitani. Their work appears in journals such as PLoS ONE, Cancer and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026